| Dr Jeffrey T Follansbee, MD | |
|
252 Mchenry St, Burlington, WI 53105-1828 | |
| (262) 763-2411 | |
| Not Available |
| Full Name | Dr Jeffrey T Follansbee |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 252 Mchenry St, Burlington, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023091824 | NPI | - | NPPES |
| 31999200 | Medicaid | WI | |
| P00258533 | Other | RAIL ROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 32725-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Ascension St Francis Hospital | Milwaukee, WI | Hospital |
| Entity Name | County Of Waukesha Department Of Finance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740403146 PECOS PAC ID: 3971405481 Enrollment ID: O20040124000130 |
News Archive
When we want to listen carefully to someone, the first thing we do is stop talking. The second thing we do is stop moving altogether. This strategy helps us hear better by preventing unwanted sounds generated by our own movements.
An increasing number of people choose a low-gluten diet, even though they are not allergic to the dietary substance. This trend has sparked public debate about whether or not low-gluten diets are recommendable for people without allergies.
Inter Press Service reports on the ongoing talks at World Water Week over "the widespread devastation caused to humans by polluted water."The article offers statistics on the health problems faced by the "more than 900 million" people without access to safe drinking water and the "estimated 2.6 billion" without access to basic sanitation.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
› Verified 7 days ago
| Entity Name | Great Midwest Pain Specialists, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598032328 PECOS PAC ID: 9436311214 Enrollment ID: O20120425000072 |
News Archive
When we want to listen carefully to someone, the first thing we do is stop talking. The second thing we do is stop moving altogether. This strategy helps us hear better by preventing unwanted sounds generated by our own movements.
An increasing number of people choose a low-gluten diet, even though they are not allergic to the dietary substance. This trend has sparked public debate about whether or not low-gluten diets are recommendable for people without allergies.
Inter Press Service reports on the ongoing talks at World Water Week over "the widespread devastation caused to humans by polluted water."The article offers statistics on the health problems faced by the "more than 900 million" people without access to safe drinking water and the "estimated 2.6 billion" without access to basic sanitation.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
› Verified 7 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194473066 PECOS PAC ID: 8628980943 Enrollment ID: O20220620000485 |
News Archive
When we want to listen carefully to someone, the first thing we do is stop talking. The second thing we do is stop moving altogether. This strategy helps us hear better by preventing unwanted sounds generated by our own movements.
An increasing number of people choose a low-gluten diet, even though they are not allergic to the dietary substance. This trend has sparked public debate about whether or not low-gluten diets are recommendable for people without allergies.
Inter Press Service reports on the ongoing talks at World Water Week over "the widespread devastation caused to humans by polluted water."The article offers statistics on the health problems faced by the "more than 900 million" people without access to safe drinking water and the "estimated 2.6 billion" without access to basic sanitation.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey T Follansbee, MD 225 S Executive Dr, Brookfield, WI 53005-4266 Ph: (262) 787-4026 | Dr Jeffrey T Follansbee, MD 252 Mchenry St, Burlington, WI 53105-1828 Ph: (262) 763-2411 |
News Archive
When we want to listen carefully to someone, the first thing we do is stop talking. The second thing we do is stop moving altogether. This strategy helps us hear better by preventing unwanted sounds generated by our own movements.
An increasing number of people choose a low-gluten diet, even though they are not allergic to the dietary substance. This trend has sparked public debate about whether or not low-gluten diets are recommendable for people without allergies.
Inter Press Service reports on the ongoing talks at World Water Week over "the widespread devastation caused to humans by polluted water."The article offers statistics on the health problems faced by the "more than 900 million" people without access to safe drinking water and the "estimated 2.6 billion" without access to basic sanitation.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
› Verified 7 days ago
Dr. Steven Ropers, Anesthesiology Medicare: Medicare Enrolled Practice Location: 709 Spring Valley Rd, Burlington, WI 53105 Phone: 262-767-6020 | |
Dr. Shailesh G. Joshi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-763-2411 | |
Andrew Miles Overturf, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-767-6000 | |
Dr. Robert O Ong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-763-2411 | |
Dr. Ernesto C Cababa, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-763-2411 | |
Dr. Paras Bhavsar, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 414-358-5457 |